SQUAWK/NEWS
Account
Theme
Account
Menu
Live News EQUITY ARTICLE M impact

Alkermes Reports Q3 2026 Revenue of $480.1 Million

Alkermes reported third-quarter 2026 GAAP net income of $16.3 million and adjusted EBITDA of $120.1 million, and reiterated its 2026 financial expectations.

ALKS
SquawkNews Desk

Alkermes reported third-quarter 2026 revenue of $480.1 million and GAAP net income of $16.3 million. Adjusted EBITDA was $120.1 million, and the company reiterated its 2026 financial expectations.Financial HighlightsBusiness HighlightsOriginal SEC Filing: Alkermes plc. [ ALKS ] - 8-K - Nov. 03, 202…

Related stories

Kimberly-Clark Reports $6.38 Billion Tendered in Debt Exchange Kimberly-Clark reports $6.38 billion tendered in its senior unsecured debt exchange. M impact | EQUITY | Nov 03, 2026, 02:11 PM UTC NextNRG Agrees to Convert $7 Million in Debt Into Preferred Shares NextNRG agreed to exchange $7 million in debt for preferred shares. M impact | EQUITY | Nov 03, 2026, 02:11 PM UTC First Watch Reports Higher Fiscal Q3 Net Income and Revenue, Updates 2026 Growth Outlook M impact | EQUITY | Nov 03, 2026, 02:11 PM UTC CIRO Halts Trading in MTY Food Group CIRO said trading in MTY Food Group has been halted. L impact | EQUITY | Nov 03, 2026, 02:11 PM UTC Ichor Holdings Reports Third-Quarter 2026 Revenue of $328.7 Million Ichor reported net income of $20.95 million, compared with a $22.85 million net loss a year earlier. Diluted EPS was $0.55, versus a loss of $0.67 per share. M impact | EQUITY | Nov 03, 2026, 02:11 PM UTC Madrigal Pharmaceuticals Reports Q3 Revenue of $431.27 Million, EPS of $1.83 Third-quarter revenue rose 50.1% year over year to $431.27 million. Net income was $55.44 million, versus a year-earlier net loss of $114.19 million; diluted EPS was $1.83 versus a M impact | EQUITY | Nov 03, 2026, 02:11 PM UTC